Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence-Reference-Cited by-同舟云学术

Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence

Published:2009-07-27 Issue:1 Volume:9 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Tassi Renata A,Calza Stefano,Ravaggi Antonella,Bignotti Eliana,Odicino Franco E,Tognon Germana,Donzelli Carla,Falchetti Marcella,Rossi Elisa,Todeschini Paola,Romani Chiara,Bandiera Elisabetta,Zanotti Laura,Pecorelli Sergio,Santin Alessandro D

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/article/10.1186/1471-2407-9-253/fulltext.html

Reference34 articles.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin. 2008, 58: 71-96. 10.3322/CA.2007.0010.

2. Baak JP, Wisse-Brekelmans EC, Langley FA, Talerman A, Delemarre JF: Morphometric data to FIGO stage and histological type and grade for prognosis of ovarian tumours. Journal of Clinical Pathology. 1986, 39: 1340-1346. 10.1136/jcp.39.12.1340.

3. Kosary CL: FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973–87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol. 1994, 10: 31-46. 10.1002/ssu.2980100107.

4. Canevari S, Gariboldi M, Reid JF, Bongarzone I, Pierotti MA: Molecular predictors of response and outcome in ovarian cancer. Crit Rev Oncol Hematol. 2006, 60: 19-37. 10.1016/j.critrevonc.2006.03.003.

5. Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, Rossi E, Falchetti M, Odicino FE, Pecorelli S, Santin AD: Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol Oncol. 2006, 103: 405-416. 10.1016/j.ygyno.2006.03.056.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of an immune-related gene prognostic model for obese endometrial cancer patients based on bioinformatics analysis;Heliyon;2024-08

2. Secretoglobins in the big picture of immunoregulation in airway diseases;Allergy;2021-08-11

3. Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer;Oncology Letters;2020-09-18

4. Decreased secretoglobin family 2A member 1expression is associated with poor outcomes in endometrial cancer;Oncology Letters;2020-07-16

5. Molecular genetics complexity impeding research progress in breast and ovarian cancers;Molecular and Clinical Oncology;2017-05-29